# CancerGuide Diagnostics, Inc. — Form D/A

CancerGuide Diagnostics, Inc. of DURHAM, NC, a company, filed a Form D amendment with the SEC on 2010-03-25. The offering totals $10.5M, of which $2.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2010-03-25
- Form: D/A
- Accession: 0001481448-10-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $10.5M
- Amount sold: $2.7M
- Remaining: $7.7M
- Investors: 5
- Date of first sale: 2010-01-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-138168

## Issuer

- Name: CancerGuide Diagnostics, Inc.
- CIK: 0001481448
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: 231 WINTERBERRY RIDGE DRIVE, DURHAM, NC, 27713
- Phone: (919) 215-5962

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| David King | Director | New York, NY |
| Garheng Kong | Director | Seattle, WA |
| MYLA LAI-GOLDMAN | Director | Durham, NC |
| Clay Thorp | Director | Durham, NC |
| William Haas | Executive Officer | Durham, NC |
| MYLA LAI-GOLDMAN | Executive Officer | Durham, NC |
| Judd Staples | Executive Officer | Durham, NC |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2010-01-26](https://search.stillhousedata.com/formd/0001481448-10-000001) | D | $10.5M | $2.0M |

## More

- [CIK 1481448 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1481448&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001481448-10-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.